Influenza A viruses (IAV) can cause lung injury and acute respiratory distress syndrome (ARDS), which is characterized by accumulation of excessive fluid (edema) in the alveolar airspaces and leads to hypoxemia and death if not corrected. Clearance of excess edema fluid is driven mostly by the alveolar epithelial Na,K-ATPase and is crucial for survival of patients with ARDS. We therefore investigated whether IAV infection alters Na,K-ATPase expression and function in alveolar epithelial cells (AECs) and the ability of the lung to clear edema. IAV infection reduced Na,K-ATPase in the plasma membrane of human and murine AECs and in distal lung epithelium of infected mice. Moreover, induced Na,K-ATPase improved alveolar fluid clearance (AFC) in IAV-infected mice. We identified a paracrine cell communication network between infected and noninfected AECs and alveolar macrophages that leads to decreased alveolar epithelial Na,K-ATPase function and plasma membrane abundance and inhibition of AFC. We determined that the IAV-induced reduction of Na,K-ATPase is mediated by a host signaling pathway that involves epithelial type I IFN and an IFN-dependent elevation of macrophage TNF-related apoptosis-inducing ligand (TRAIL). Our data reveal that interruption of this cellular crosstalk improves edema resolution, which is of biologic and clinical importance to patients with IAV-induced lung injury.
Introduction
Influenza A viruses (IAV) infect cells in the alveolus and induce primary viral pneumonia, which can progress to acute respiratory distress syndrome (ARDS) with high mortality (1) . IAV-induced lung injury is characterized by exaggerated inflammatory responses and loss of barrier function, resulting in edema formation and severe hypoxemia (1) (2) (3) (4) . Resolution of inflammation together with repair of the damaged epithelium and edema fluid clearance are crucial events in the recovery phase of ARDS (5) . It has been demonstrated that impaired edema resolution in ARDS patients is strongly correlated with increased mortality (6, 7) . Therefore, understanding the molecular mechanisms by which IAV infection decreases lung edema clearance might provide therapeutic targets to improve clinical outcome in IAV-induced ARDS.
Fluid reabsorption is driven by an osmotic gradient generated by the coordinated regulation of the apically expressed epithelial sodium channel (ENaC) and the basolaterally expressed Na,K-ATPase. Sodium ions enter the epithelial cells via ENaC and are transported out of cells by the Na,K-ATPase, which promotes the aquaporin-driven or transcellular removal of water from the alveolar airspace (8, 9) . The Na,K-ATPase is a heterodimeric protein that couples the transfer of 3 sodium ions out of the cell in exchange for the intracellular transfer of 2 potassium ions with energy provided by the hydrolysis of ATP. It is therefore the major driver of vectorial sodium transport and has been shown to be an important determinant and limiting factor of net fluid clearance (10) (11) (12) (13) (14) (15) .
During IAV infection of the distal respiratory tract, the functional and structural impairment of the tight alveolar epithelial cell (AEC) layer, and thus the alveolo-capillary barrier results in fluid leakage from the vascular compartment into the alveolar space and persistent edema (4, 16, 17) . However, the underlying mechanisms are not well understood. Recent findings suggest that an overly exuberant inflammatory response may contribute to alveolar barrier disruption via a mechanism that requires both tissue-resident and BM-derived macrophages (BMM) (4, 16, 18, 19) . We have recently demonstrated that the cytokine TNFrelated apoptosis-inducing ligand (TRAIL), when released in excessive amounts from aveolar macrophages (AMs) upon autocrine IFNβ stimulation, significantly contributes to IAV-induced immunopathology (4, 16) .
Here, we identify a paracrine communication network between different cellular subsets within the inflamed alveolus, which we found is critical to affect alveolar fluid clearance (AFC) in IAV-induced lung injury. In vitro and in vivo IAV infection led Influenza A viruses (IAV) can cause lung injury and acute respiratory distress syndrome (ARDS), which is characterized by accumulation of excessive fluid (edema) in the alveolar airspaces and leads to hypoxemia and death if not corrected. Clearance of excess edema fluid is driven mostly by the alveolar epithelial Na,K-ATPase and is crucial for survival of patients with ARDS. We therefore investigated whether IAV infection alters Na,K-ATPase expression and function in alveolar epithelial cells (AECs) and the ability of the lung to clear edema. IAV infection reduced Na,K-ATPase in the plasma membrane of human and murine AECs and in distal lung epithelium of infected mice. Moreover, induced Na,K-ATPase improved alveolar fluid clearance (AFC) in IAV-infected mice. We identified a paracrine cell communication network between infected and noninfected AECs and alveolar macrophages that leads to decreased alveolar epithelial Na,K-ATPase function and plasma membrane abundance and inhibition of AFC. We determined that the IAV-induced reduction of Na,K-ATPase is mediated by a host signaling pathway that involves epithelial type I IFN and an IFN-dependent elevation of macrophage TNF-related apoptosis-inducing ligand (TRAIL). Our data reveal that interruption of this cellular crosstalk improves edema resolution, which is of biologic and clinical importance to patients with IAV-induced lung injury.
Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection parallel by adenoviral delivery prior to IAV infection or increased Na,K-ATPase plasma membrane abundance by treatment of AEC by the β-adrenergic agonist salbutamol (15, 24) . Adenoviral overexpression of NKAα1 and NKAβ1 indeed restored total NKAα1 in IAV-infected AEC to baseline levels in vitro ( Figure  2C ) and also plasma membrane expressed NKAα1 in vivo ( Figure  2D ). Similarly, salbutamol treatment increased NKAα1 plasma membrane abundance both in vitro and in vivo ( Figure 2 , B and D). Importantly, increased NKAα1 expression on alveolar epithelial cells directly contributed to improved AFC after IAV infection in vivo ( Figure 2E ). In line, direct blockade of Na,K-ATPase activity by its specific inhibitor ouabain resulted in decreased AFC (Supplemental Figure 2) .
A soluble mediator released from infected macrophages and AEC leads to decreased plasma membrane NKAα1 protein abundance. Given our previous findings that alveolar and BMM contribute to AEC damage (4, 16) and that NKAα1 was particularly reduced within strongly inflamed regions of the lung, we explored whether presence of AMs or BMM would further inhibit NKAα1 after IAV infection. Indeed, epithelial cell NKAα1 protein abundance of noninfected AEC was significantly reduced in the presence of infected AM alone and further reduced after infection of both AEC and either AM ( Figure 3A ) or BMM ( Figure 3B ). Notably, plasma membrane-expressed NKAα1 was significantly decreased on noninfected AEC in presence of IAV-infected BMM ( Figure  3 , C and D). As AEC and AM/BMM were cultured without direct physical contact to each other, these results suggest that paracrine crosstalk via a soluble macrophage-produced mediator leads to NKAα1 downregulation and that additional infection of AEC further reduced total and plasma membrane-expressed NKAα1 (Figure 3, C and D). We therefore investigated whether the reduction of NKAα1 at the plasma membrane after IAV infection in the AEC monoculture was similarly mediated by paracrine signaling rather than by IAV infection itself. We correlated viral protein expression (hemagglutinin, HA) to NKAα1 plasma membrane abundance ( Figure 3E ), and indeed, plasma membrane NKAα1 was predominantly reduced in the adjacent noninfected IAV-HAfraction of mAEC ( Figure 3F ) and hAEC ( Figure 3G ), as well as of alveolar cells after IAV infection in vivo ( Figure 3H ). Furthermore, treatment of mAEC with conditioned media of infected but not of PBStreated mAEC was sufficient to decrease NKAα1 plasma membrane protein abundance ( Figure 3I ).
Paracrine signaling of epithelial type I IFN-and IFN-dependent macrophage TRAIL leads to reduced plasma membrane NKAα1 protein abundance in AEC. To identify soluble factors within the AEC-macrophage crosstalk network that mediated the observed effect on NKAα1 plasma membrane expression in AECs, we analyzed coculture supernatants for proinflammatory cytokines by ELISA and cytometric bead array (data not shown). We found that IFNα -and to a minor extent IFNβ ( Figure 4A and Supplemental Figure 3 ) -were released from infected AEC, whereas BMM did not increase IFNα release upon IAV infection ( Figure 4A ). We recently demonstrated that type I IFNs are potent inducers of TNF family cytokines in AM, particularly of TRAIL (4, 16) . Likewise, IAV infection of BMM with IAV led to a significant release of TRAIL ( Figure 4B ), which was type I IFN-dependent as demonstrated by use of BMM derived from type I IFN receptor-deficient to reduced plasma membrane expression of alveolar epithelial Na,K-ATPase and thus impaired lung edema clearance in vivo. We discovered that IAV-infected epithelial cells and macrophages, as well as noninfected neighboring epithelial cells, establish a specific communication network via epithelial type I IFN and especially the IFN-dependent, macrophage-expressed TRAIL, which determines Na,K-ATPase plasma membrane protein abundance and, thus, edema clearance during IAV infection. The identified pathways underlying this macrophage-epithelial crosstalk are amenable to therapeutic targeting to improve alveolar edema clearance in vivo and putatively improve outcome in patients with severe IAV-induced lung injury.
Results
IAV infection leads to decreased Na,K-ATPase protein abundance and impaired AFC. Murine intratracheal infection with H1N1 IAV A/PR/8/34 resulted in alveolar edema at day 7 postinfection (d7 pi) not present in PBS-treated control groups ( Figure 1A , upper panel). The excessive fluid in the alveolar airspace upon IAV infection was associated with severe hypoxemia at d7 pi ( Figure 1B ) and substantial impairment of AFC in vivo detected at d2 and more pronounced at d7 pi ( Figure 1C ). We therefore assessed Na,K-ATPase α1 subunit (NKAα1) protein abundance, after in vitro H1N1 IAV infection of primary AEC. Gene expression levels of NKAα1 did not change after IAV infection (data not shown); however, the total cell protein abundance was significantly decreased at 16 hours pi (16h pi) and 24h pi in murine AEC (mAEC) as well as in in primary human AEC (hAEC) at 16h pi ( Figure 1 , E and F). In addition, IAV infection was associated with reduction of the immunofluorescent signal for NKAα1 in vivo, which was particularly found within highly inflamed aveolar regions but was found less within less inflamed alveolar regions; noninfected mice showed high NKAα1 expression ( Figure 1A , lower panels).
Alveolar epithelial plasma membrane NKAα1 is decreased after IAV infection in vitro. Na,K-ATPase is mostly stored in intracellular compartments but contributes to active ion transport and AFC when recruited to the basolateral cell membrane (20, 21) . Therefore, we assessed NKAα1 plasma membrane abundance by flow cytometry (gating strategy in Figure 1D ), as well as by plasma membrane biotinylation and subsequent pulldown in in vitro-infected AEC. Both assays revealed reduced NKAα1 protein abundance at the plasma membrane in mAEC and hAEC following IAV infection (Figure 1 , G-J).
Reduced alveolar epithelial plasma membrane expression of NKAα1 causes impaired AFC after IAV infection in vivo. We next investigated whether Na,K-ATPase levels were affected by IAV infection in vivo and assessed NKAα1 plasma membrane protein abundance on distal lung epithelial cells, largely comprising type II alveolar epithelial cells (Supplemental Figure 1 ; supplemental material available online with this article; doi:10.1172/ JCI83931DS1), by flow cytometry. IAV infection resulted in a reduction of plasma membrane NKAα1 on alveolar epithelial cells in vivo already on d2 pi and most pronounced on d7 pi ( Figure  2A ), which correlated with the reduced fluid clearance depicted in vivo ( Figure 1C ). To assess if decreased levels of NKAα1 were a direct cause of reduced AFC capacities after IAV infection, we either induced overexpression of NKAα1 and NKAβ1 (22, 23) in dance was rescued to baseline levels at 24h pi, whereas Trail -/-AEC still displayed a strong decrease in NKAα1 protein abundance ( Figure 4E ). Moreover, transfer of conditioned media from either PBS-treated or PR8-infected AEC to Ifnar -/-AEC did not reduce NKAα1 plasma membrane abundance ( Figure 4F ), suggesting that in absence of macrophages, NKAα1 surface downregulation was solely dependent on signaling through type I IFN. We next performed coculture infections using AEC and BMM from WT, Ifnar -/-, Trail -/-, or Dr5 -/-(TRAIL receptor) mice and assessed NKAα1 plasma membrane abundance after IAV infection. These (Ifnar -/-) mice ( Figure 4C ). AEC did not release TRAIL in response to IAV infection ( Figure 4B ). Treatment of uninfected AEC with either recombinant IFNα (rIFNα) or rTRAIL decreased NKAα1 protein abundance at the plasma membrane, and combined treatment with both IFNα and TRAIL reduced NKAα1 to similar levels as coinfection of AEC and BMM ( Figure 4D ). rIFNβ at levels found when released by infected AEC did not affect NKAα1 levels (Supplemental Figure 3 ). When using Ifnar -/-AEC to block paracrine IFNα signaling between A/PR/8/34 (H1N1)-infected (PR8infected) and noninfected AEC in monoculture, NKAα1 abun- resulted in partial decrease of plasma membrane NKAα1 ( Figure 4G ). Addition of recombinant human IFNα and/or recombinant human TRAIL to cultured hAEC reduced their ability for vectorial water transport as measured by changes in FITC-dextran concentrations in the apical versus basal medium of confluent hAEC to a similar extent as IAV infection (Figure 4H ), whereas vectorial water transport of hAEC cocultured with primary human AM was significantly increased in the presence of neutralizing antibodies directed against IFNα and TRAIL after IAV infection ( Figure 4I ). Together, these data indicate that IAV-induced downregulation of NKAα1 and reduced ability for fluid transport depend on a signaling network between AEC and macrophages, involving epithelial type I IFNand IFN-dependent macrophage TRAIL.
The TRAIL-mediated reduction of NKAα1 levels is induced independently of epithelial cell apoptosis. Previous work on the role of macrophage-released TRAIL during IAV infection demonstrated its contribution to extrinsic AEC apoptosis induction and to loss of barrier function (4, 16). To exclude that the observed effects of TRAIL on NKAα1 expression levels in noninfected AEC were caused by TRAIL-mediated induction of apoptosis, we inhibited activation of the effector caspase-3 by addition of the specific inhibitor Z-DEVD (25, 26) after IAV infection. In vitro and in vivo treatment with Z-DEVD resulted in significantly reduced levels of apoptotic alveolar epithelial cells after IAV infection for 24 hours and 7 days, respectively (Supplemental Figure  4 , A and C). Moreover, application of Z-DEVD at d5 and d6 pi in vivo resulted in reduced activation of caspase-3 in AEC at d7 pi (Supplemental Figure 4D ). However, NKAα1 plasma membrane expression was not significantly altered after IAV infection by inhibition of caspase-3 activation, both in vitro as well as in vivo (Supplemental Figure 4 , B and E). Accordingly, AFC rates were reduced to similar levels at d7 pi in IAV-infected mice or IAV-infected mice studies revealed that lack of IFNAR signaling in AEC, together with lack of TRAIL in BMM, fully prevented NKAα1 downregulation in AEC. Partial blockade of the IFN-TRAIL signaling loop by combination of Ifnar -/-AEC with WT BMM (allowing BMM TRAIL action), or of either WT AEC with Trail -/-BMM or Dr5 -/-AEC with WT BMM (allowing AEC type I IFN signaling), correspondingly The IFN/TRAIL-dependent reduction of NKAα1 plasma membrane abundance is mediated via AMPK. Given that Na,K-ATPase endocytosis was reported to be mediated by activation of AMPactivated protein kinase (AMPK) during lung injury-associated treated with Z-DEVD (Supplemental Figure 4F ). Together, these data demonstrate that TRAIL-induced reduction of plasma membrane-expressed NKAα1, and its effects on net AFC are mediated independently of the induction of alveolar epithelial apoptosis. Figure 6A) prevented the IAV-induced reduction in NKAα1 plasma membrane abundance and in AFC in vivo at d2 pi ( Figure 6, A and B) . Additionally, pharmacological inhibition of AMPK signaling in vivo by application of Compound C at d5 pi significantly increased NKAα1 plasma membrane abundance and AFC at d7 after IAV infection ( Figure 6 , C and D). Neither DN-AMPK instillation nor Compound C treatment impacted on viral clearance (Supplemental Figure 6B and data not shown).
IFN and BMM-released TRAIL contribute to reduced NKAα1 plasma membrane abundance and impaired AFC in vivo and are amenable to therapeutic targeting after IAV infection. We next investigated whether Na,K-ATPase levels were also dependent on the IFN/TRAIL signaling network in vivo. Interestingly, Ifnar -/mice (deficient for both IFNα ligation by the alveolar epithelium and for IFNβ-dependent production of TRAIL by macrophages) were protected from IAV-induced reduction of NKAα1 plasma membrane expression at d7 pi ( Figure 7A ). Consistent with our in vitro findings demonstrating that TRAIL released from BMM mediated the reduction of membrane NKAα1 abundance during IAV infection, both Trail -/mice and mice deficient for C-C chemokine receptor type 2 (Ccr2 -/-), which are unable to recruit macrophages from the BM to the lung after IAV-infection (35) , were protected from NKAα1 loss on distal lung epithelial cells in response to IAV infection when compared with WT animals (Figure 7, A and B) . Moreover, we demonstrate, by intrapulmonary transfer of BMM flow-sorted (Supplemental Figure 7 ) from the lungs of WT or Trail -/mice at d7 after IAV infection into infected Ccr2 -/mice, that rescue of NKAα1 expression in Ccr2 -/mice at d7 pi is lost in the presence of WT BMM but maintained after transfer of Trail -/-BMM ( Figure 7B) . Accordingly, the IFN/TRAIL-mediated loss of surface NKAα1 significantly reduced AFC in WT mice after IAV infection but not in Ifnar -/-, Trail -/-, or Ccr2 -/mice ( Figure  7C ), which corresonded with decreased edema accumulation as quantified by wet-to-dry lung weight ratios in Ifnar -/and Trail -/mice (Supplemental Figure 8) . Additionally, fluid clearance was completely restored in Ccr2 -/mice that were supplemented with Trail -/-BMM but not in Ccr2 -/mice receiving WT BMM ( Figure  7D ). Moreover, in vivo targeting of the IFN/TRAIL signaling network by administration of anti-IFNα and anti-TRAIL neutralizing antibodies resulted in enhanced NKAα1 protein abundance on the alveolar epithelium and significantly improved AFC capacities in IAV-infected WT mice, resulting in decreased edema formation and reduced morbidity, as demonstrated by body weight loss, and reduced overall morbidity scoring (Figure 8 , A-D, and Supplemental Table 1 ). These data highlight a crucial role for the paracrine crosstalk involving IFN and macrophage-released TRAIL signaling for impairment of Na,K-ATPase-driven alveolar edema clearance capacity after IAV infection in vivo and suggest that targeting this axis is a promising approach to improve fluid clearance in humans after IAV-induced ARDS.
Discussion
Influenza virus pneumonia is characterized by infection of airway and alveolar epithelial cells and can rapidly progress to ARDS with dismal clinical outcome (1, 3) . A functional impairment of the alveolar epithelial barrier after IAV infection results in pulmonary edema accumulation and impaired fluid reabsorption, which is closely correlated to mortality in ARDS patients (6, 7) . Here, we report a mechanism by which a paracrine communication network between different populations of infected and adjacent cells in the alveolus downregulates alveolar epithelial Na,K-ATPase and thus inhibits AFC in response to IAV infection.
Our data demonstrate that the plasma membrane NKAα1 protein abundance is reduced after IAV infection, indicating that the key function of Na,K-ATPase -active sodium transport out of the cell -is impaired (11, 12) . Vectorial sodium and fluid clearance is a coordinated process that requires the electrochemical gradient generated by the basolateral Na,K-ATPase, thereby constituting the driving force of edema reabsorption. Sodium and water transport can also be regulated by the apically located ENaC and by chloride channels such as the cystic fibrosis transmembrane receptor (CFTR). In previous work, investigators reported that the levels of ENaC and CFTR were reduced in response to viral infection via a direct interaction with the viral matrix protein (36, 37) . In contrast, we found that plasma membrane Na,K-ATPase protein abundance was disproportionately jci.org Volume 126 Number 4 April 2016
The type I IFNs play a complex role in the immune response to IAV infection. They are rapidly produced by AECs after viral infection to activate antiviral transcriptional programs in both epithelial and immune cells in the lung that are important for viral clearance. Furthermore, they may play a role in limiting the severity of the immune response via the production of IL-10 (38) (39) (40) . Accordingly, IFNs have been suggested as potential therapeutic strategies to promote anti-IAV host defenses, particularly when applied as prophylactic treatment or early after onset of the infection (41, 42) . Our data, however, indicate that reduced in neighboring, noninfected epithelial cells, suggesting that NKAα1 reduction is not mediated by direct interaction with a viral component but relies on paracrine signals released from the infected epithelial cells and macrophages. These findings highlight the need to understand influenza A infection in the context of integrated signaling networks involving different cell populations in the lung. Using a coculture system, we demonstrate the importance of epithelial IFNα-and IFN-induced macrophage TRAIL, which downregulated the AEC NKAα1 both in the presence and absence of IAV infection. that the macrophage TRAIL/epithelial DR5 interaction exerts a role in virus-induced lung injury by activating the energy sensor AMPK. Of note, we demonstrated that TRAIL/AMPK-mediated reduction of NKAα1 plasma membrane abundance and impairment of AFC was independent of TRAIL-induced epithelial cell apoptosis induction in vivo (4, 16) , as inhibition of AEC apoptosis by application of Z-DEVD did not impact on NKAα1 reduction after IAV infection. Activation of the metabolic sensor/regulator AMPK, under normal conditions, upregulates ATP generating and downregulates ATP-consuming mechanisms to promote cellular survival during metabolic stress (34, 55, 56) . Of note, Herrero-Martín et al. demonstrated that rTRAIL was able to activate AMPK in immortalized epithelial cells and, thus, promote autophagy, a cytoprotective mechanism rendering cells more resistant to deleterious challenges (57) , highlighting the complexity of the IFN/TRAIL network in cellular injury and protection in response to cellular stress. The Na,K-ATPase has been well documented to be targeted for downregulation via a pathway that requires AMPK and subsequent activation of PKCζ in response to stimuli that threaten metabolic homeostasis, including alveolar hypercapnia and hypoxia (27, 28) . We demonstrate activation of AMPK signaling by paracrine mediators in response to IAV infection, resulting in reduced vectorial sodium transport. Inhibiting AMPK in vivo by DN-AMPK or Compound C treatment attenuated the Na,K-ATPase downregulation and restored AFC rates in IAV-infected mice. These data highlight AMPK as a critical regulator of AFC in pulmonary injury in vivo, suggesting it as a therapeutic target for the treatment of IAV (58) . At low levels, however, IFN/TRAIL-and AMPK-mediated reductions in vectorial sodium transport and fluid clearance in the IAV-infected lung may be beneficial, particularly during early stages of the disease when viral replication occurs and viral loads still increase. It has been reported that alterations of sodium currents within the IAV-infected cell show at later time points, when the infection has spread to the alveolar compartment and progresses to lung injury, IFNs may also have a detrimental effect, evidenced by imbalanced inflammation and loss of crucial AEC functions such as edema clearance.
An important source of IFN and other proinflammatory cytokines in IAV-induced innate immune responses are AM-and CCR2-recruited BMM (43) (44) (45) . Tissue resident AM play key roles in sensing viral infection and activating the initial innate and later adaptive immune responses to IAV infection (46) . In concert with the macrophage populations recruited upon infection, they establish a proinflammatory environment by production and release of mediators such as IFN, leading to enhanced viral clearance and better disease outcomes (43, 47) . However, it is well recognized that excessive production of cytokines during IAV infection contributes to lung injury, which impacts severity and outcome (48, 49) , as shown for highly pathogenic avian influenza H5N1 or the pandemic 2009 H1N1 virus (50, 51) . In particular, resident and recruited macrophages have been attributed as key roles in amplifying lung injury after IAV-infection by orchestrating an overly exuberant inflammatory response to IAV infection, worsening IAVinduced lung inflammation, lung injury severity, and mortality and hampering resolution of inflammation (4, 16, 44-48, 49, 50) . In this regard, we and others revealed that IFNβ-induced autocrine activation of the death ligand TRAIL in BMM substantially deteriorates lung injury by promoting AEC injury after IAV infection (16, 52) . Our current data provide important insights into these mechanisms, revealing a role of AEC-produced IFNα and macrophage-produced IFNβ-dependent TRAIL signaling within the alveolar cell-cell communication network in promoting impairment of epithelial barrier function and alveolar fluid homeostasis.
TRAIL has been widely associated with induction of extrinsic apoptosis in a variety of cells, including leukocyte subsets and cancer cells, via DR5 (53, 54 ). In the current study, we provide evidence Trail -/mice and mice lacking BMM recruitment from the circulation (Ccr2 -/-) were similarly protected from IAV-induced epithelial Na,K-ATPase downregulation. Of course, we cannot fully exclude that additional factors (e.g., infection-induced activation of intracellular pathways) affecting Na,K-ATPase function rather than mere surface expression (e.g., ion or ATP affinity or channel open probability) might have further influence on net AFC in our different in vivo models, as we observe substantially but not fully restored AFC rates ranging between similar levels in all gene-deficient mice applied (Ifnar -/-, Trail -/-, and Ccr2 -/-). Further investigation on the effect of TRAIL released from recruited BMM after infection was performed via pulmonary transfer of WT but not Trail -/-BMM into Ccr2 -/mice after IAV infection, which led to decreased NKAα1 abundance and AFC similar to the decrease observed in IAV-infected WT mice and demonstrated the crucial role for TRAIL-expressing macrophages in the inhibition of AFC in vivo. We acknowledge that, in these studies, we did not address effects on overall survival, nor the consequences of TRAIL-deficiency on virus clearance, but we could importantly show that therapeutic blockade of the IFN/TRAIL network by neutralizing antibodies in vivo proved to increase NKAα1 expression and AFC after IAV infection. Considering that anti-TRAIL treatment was recently demonstrated to elicit profound effects in attenuating IAV-induced barrier disruption and to prevent pneumococcal superinfection (61), we suggest that therapeutic targeting of the here described signaling axis will not only ameliorate AFC after IAV infection, but will furthermore protect from TRAIL-mediated lung injury and complications thereof. We anticipate that targeting particularly macrophage TRAIL alone or together with epithelial an adverse effect on viral replication (59) . Therefore, the resulting changes in intracellular sodium or potassium might interfere with viral signaling, providing an antiviral defense strategy for the infected cell. Alternatively, reduced Na,K-ATPase function might represent activation of a stress response pathway, perhaps secondary to changes in intracellular calcium, that reduces the susceptibility of neighboring epithelial cells to viral infection (59) . Consistent with this hypothesis, we found that signaling through IFNAR and DR5 by IFN and TRAIL, respectively, activates AMPK via a pathway that requires CaMKKβ, which is in turn activated by increases in intracellular calcium (58) . While the links between calcium signaling and the AMPK during influenza A infection have not been completely elucidated, previous studies have shown that, in hypoxic conditions, an influx of extracellular calcium through stromal interaction molecule 1-activated (STIM1-activated) calcium release-activated calcium channels (CRAC channels) can lead to CaMKKβ-and AMPK-mediated endocytosis of Na,K-ATPase (27) . Wang et al. demonstrated that the calcium-dependent tyrosine kinase Pyk2 interacts with the IFNAR-associated tyrosine kinases Jak1/Tyk2 (60), providing a possible link to CaMKKβ activation.
Our in vitro studies provide complementary lines of evidence demonstrating an additive role for epithelial-produced IFNαand IFN-dependent macrophage TRAIL in the downregulation of Na,K-ATPase plasma membrane protein abundance during IAV infection. Concordant with our in vitro findings, Ifnar -/mice deficient in the IFNα/β receptor, and thus compromised in both epithelial IFN crosstalk and IFN-dependent induction of macrophage TRAIL expression, displayed less reduction of Na,K-ATPase and were less impaired in AFC after IAV challenge. experiments. AEC suspensions with a purity >90% were used for further experiments. Murine resident AMs were isolated by bronchoalveolar lavage as described (16) and cultured for 2 hours before treatment. Human resident AMs were gained from bronchoalveolar lavage fluid (BALF) of patients who did not show any accumulation of recruited inflammatory cells according to differential counts of pappenheim-stained cytospins. BMM were isolated from femurs and tibias and cultured in the presence of mouse recombinant granulocyte/ macrophage-CSF (GM-CSF) at 25 ng/ml for 10 days. Infection protocols. Cells were infected with PR8 at a multiplicity of infection (MOI) of 0.1 as previously described (16) . For coculture experiments, bottom-seeded AM or BMM were combined with AEC seeded on transwells after infection of only macrophages or of both cell types with PR8. Of note, an abortive replication cycle occurred in AM and BMM, as described in Högner et al. (16) , and ensured that in the AM/BMM infection-only conditions, no virus was transferred to the epithelial cell layer excluding AEC infection. For in vitro experiments, recombinant murine TRAIL (R&D Systems, 100 pg/ml), recombinant murine GM-CSF (R&D Systems, 25 ng/ml) recombinant mouse IFNα and -β (PBL Interferon Source, 25 U/ml; R&D Systems, 10-100 ng/ ml), recombinant human IFNα (R&D Systems, 150 pg/ml), recombinant human TRAIL (R&D Systems, 100 pg/ml), anti-human IFNα neutralizing antibody (R&D Systems, 0.5 μg/ml), anti-human TRAIL neutralizing antibody (R&D Systems, 0.1 μg/ml), and the following chemical inhibitors were used: AICAR, AMPK inhibitor Compound C, (5Z)-7-Oxozeanol (Curvularia sp), STO-609 (all Calbiochem) and BAPTA-AM (Invitrogen). Conditioned media of 16h-infected mAEC cultured in 6-well plates was transferred to uninfected mAEC AMPK downstream signaling might be beneficial with respect to alveolar barrier protection and edema reabsorption, without compromising antiviral host defense.
In conclusion, we describe a paracrine pathway in the IAV-infected lung that links macrophage and epithelial signaling to the downregulation of the Na,K-ATPase in the noninfected fraction of AECs. This decrease is mediated by AEC-released IFNα directly and is strongly amplified through IFNα/β-induced release of TRAIL from recruited macrophages, resulting in inhibition of lung edema clearance (Figure 9) . A timely modulation of this pathway might represent a novel strategy to improve fluid reabsorption and, thus, outcomes in IAV-induced lung injury and ARDS. Cell isolation and culture. Primary mAEC or hAEC were isolated as previously described (16, 66) , seeded on 4 μm-pore size transwells (Corning Inc.), and cultured for 3 and 5 days, respectively, prior to trations, directly correlating with the amount of BSA in the solution, were analyzed from the initial instillate and the reaspirated fluid using a microplate reader (Bio-Rad, 620-nm filter) and AFC was calculated as follows: AFC = 1 -(C 0 /C 30 ), where C 0 is the protein concentration before instillation and C 30 is the protein concentration of the sample reaspirated after 30 minutes of ventilation. Ex vivo measurement of vectorial water transport. Primary human AEC were seeded in 0.4 μm-pore size transwell cell culture dishes (Corning Inc.) and cultured until achieving electrochemical resistances of ≥800 Ω/cm 2 as measured by Millicell-ERS2 device (EMD Millipore). Cells were infected with PR8 at MOI 0.1 or PBS treated for 1 hour at 37°C and then supplied with 3 mg/ml 70 kDa FITC-dextranlabeled (Sigma-Aldrich) cell culture media including selected inhibitors at indicated concentrations. After 6 hours of incubation at 37°C, apical and basal media were analyzed for FITC-dextran concentration (FL X 800, Bio-Tek). Cells were analyzed microscopically for bound FITC-dextran without apparent differences in the treatment groups. Vectorial water transport was calculated by changes in FITCdextran concentration between apical (C a ) and basal (C b ) media in comparison with starting conditions (C 0 ):
Methods
Histology. Lungs were clipped at the trachea, perfused with 4% paraformaldehyde (PFA), removed, and fixed for 24 hours in 4% PFA. Lungs were embedded in Paraffin (Leica ASP200S), cut into 5-μm thick sections, and either stained with NKAα1 (clone C464.6, EMD Millipore) after antigen retrieval with 10 mM sodium citrate at 95°C for 20 minutes or stained with H&E (Merck). Analysis was performed with an EVOS FL imaging system (Thermo Fisher Scientific).
Cell surface labeling and Western blot. Cell surface labeling and Western blot were performed as previously described (16, 69) . For immunostaining, the following antibodies were used: NKAα1, AMPKα (clone 40H9) and phospho-ACC (clone S79, both Cell Signaling Technology), polyclonal Glut1 (catalog 07-1401, EMD Millipore), β-actin (clone Poly6221, BioLegend), GAPDH (clone 14C10, Cell Signaling Technology), secondary mouse or rabbit HRP (clones 7076 and 7074, Cell Signaling Technology). Bands were detected cultured in 12-well plates and incubated for 2 hours. For in vivo infection, mice were intratracheally inoculated with 500 plaque-forming units (pfu) PR8 or 10 5 pfu A/Udorn/307/1972 (H3N2, also known as Udorn) diluted in 70-μl sterile PBS. Endotracheal delivery of adenovirus was performed at 1 × 10 9 pfu in 50% surfactant vehicle as described previously (24) . Adenoviruses carrying either no additional construct (Ad-Null) -or expressing DN-AMPK, Ad-NKAα1, or Ad-NKAβ1were cloned at ViraQuest Inc. Of note, NKAβ1 -which was shown to be a crucial mediator for correct heterodimerization of the Na,K-ATPase (22, 67) -was coexpressed to ensure presence of sufficient levels of NKAβ1 to support functional Na,K-ATPase formation.
Of note, transduction efficiency was >90% in AEC, as verified by FACS for mCherry in EpCAM + cells (not shown). Neutralizing antibodies against IFNα (10,000 IU/mouse, rabbit polyclonal Ab to mouse IFNα, PBL Interferon Source) were administered intratracheally at d3 pi, and neutralizing antibodies against TRAIL (150 μg/mouse, LEAF anti-mouse CD253, BioLegend) were given i.p. at d3 and d5 pi as established previously (16) . Infected mice were monitored 1-3 times per day.
In vivo measurement of AFC. The rate of fluid removal from the alveolar airspace was measured by assessment of changes in Evans blue-tagged albumin in an iso-osmolar alveolar instillate over 30 minutes as previously described (24) . In short, mice were anesthetized, placed on a heating pad, and maintained in supine position. Body temperature was monitored using an anal probe and maintained at 37°C with heating pad and lamp. After reaching stable anesthesia, mice were cannulated with a shortened 18-gauge i.v. catheter, paralyzed with 2.0 mg/kg pancuronium bromide applied i.p., and ventilated via catheter connected to a mouse respirator (Harvard Apparatus) using a tidal volume of 10 ml/kg (equivalent of 0.2 ml) at a frequency of 160 breaths per minute and 100% of oxygen, as described by Hardiman et al. (68) . Iso-osmolar NaCl solution (324 mOsm; 300 μl) containing 5% Evans blue-tagged (0.15 mg/ml) bovine serum albumin were installed via the catheter over a time period of 30 seconds, followed by 0.1 ml of air; then, mice were ventilated over 30 minutes. Evans blue concen- challenge with 500 pfu PR8. BMM were identified by the signature CD45 + GR-1 + Ly6G -CD11b hi CD11c lo SiglecF lo and flow sorted (Supplemental Figure 5 ). The purity of sorted BMM (≥95%) was ensured by flow cytometric analysis, as well as by pappenheim stained cytospins. Sorted BMM were resuspended in sterile PBS, and 30,000 cells in 50 μl were transferred intratracheally to PR8-infected Ccr2 -/mice on d3 pi; the mice were analyzed for Na,K-ATPase-mediated fluid clearance on d7 pi. Statistics. All data are given as mean ±SEM. Statistical significance was analyzed by unpaired 2-tailed Student's t test or by 1-way ANOVA and post-hoc Tukey (GraphPad Prism 5). A P value less than 0.05 was considered significant. *P < 0.05; **P < 0.01; ***P < 0.005.
Study approval. Animal experiments were approved by the regional authorities of the State of Hesse (Regierungspräsidium Giessen) and by the Institutional Animal Care and Use Committee at Northwestern University. Human lung tissue was obtained from patients who underwent lobectomy after informed written consent. Use of human lung tissue and BALF samples was approved by the University of Giessen Ethics Committee.
